Experience with basiliximab in pediatric liver graft recipients

Transplant Proc. 2001 Nov-Dec;33(7-8):3606-7. doi: 10.1016/s0041-1345(01)02551-9.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Acute Disease
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Basiliximab
  • Body Weight
  • Child
  • Child, Preschool
  • Cyclosporine / therapeutic use
  • Dose-Response Relationship, Drug
  • Drug Monitoring
  • Drug Therapy, Combination
  • Graft Rejection / pathology
  • Graft Rejection / prevention & control*
  • Humans
  • Hypertension / epidemiology
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Infant
  • Kidney / drug effects
  • Kidney / pathology
  • Liver Transplantation / immunology*
  • Postoperative Complications / epidemiology
  • Prednisolone / therapeutic use
  • Recombinant Fusion Proteins*

Substances

  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Recombinant Fusion Proteins
  • Cyclosporine
  • Basiliximab
  • Prednisolone